APEX Orthopedics Investments has been established as an asset management company dedicated to fostering innovation and device development in the foot and ankle orthopedic sector.
The founding group brings over four decades of collective experience in successful product development, having launched 200+ products, generating a cumulative revenue of USD $3 billion.
Focused on investing in and incubating Class II and Class III devices, APEX Orthopedics Investments is committed to driving novel solutions in fixation hardware, midfoot arthrodesis, midfoot arthroplasty and Achilles tendon. The company currently boasts 12 pending patents in the United States and internationally, along with 73 invention disclosures.
APEX Orthopedics Investments has organized its intellectual property into four distinct portfolio companies, each focused on addressing critical needs within the field. These portfolio companies are poised to drive significant advancements and improvements in orthopedic care.
“Our mission at APEX Orthopedics Investments is to catalyze innovation within the foot and ankle orthopedic industry,” stated Chris Banas, CEO and President of APEX Orthopedics Investments. “Through strategic investments and incubation, we aim to revolutionize patient care and outcomes while empowering orthopedic professionals with cutting-edge solutions.”
APEX Orthopedics Investments has been established as an asset management company dedicated to fostering innovation and device development in the foot and ankle orthopedic sector.
The founding group brings over four decades of collective experience in successful product development, having launched 200+ products, generating a cumulative revenue...
APEX Orthopedics Investments has been established as an asset management company dedicated to fostering innovation and device development in the foot and ankle orthopedic sector.
The founding group brings over four decades of collective experience in successful product development, having launched 200+ products, generating a cumulative revenue of USD $3 billion.
Focused on investing in and incubating Class II and Class III devices, APEX Orthopedics Investments is committed to driving novel solutions in fixation hardware, midfoot arthrodesis, midfoot arthroplasty and Achilles tendon. The company currently boasts 12 pending patents in the United States and internationally, along with 73 invention disclosures.
APEX Orthopedics Investments has organized its intellectual property into four distinct portfolio companies, each focused on addressing critical needs within the field. These portfolio companies are poised to drive significant advancements and improvements in orthopedic care.
“Our mission at APEX Orthopedics Investments is to catalyze innovation within the foot and ankle orthopedic industry,” stated Chris Banas, CEO and President of APEX Orthopedics Investments. “Through strategic investments and incubation, we aim to revolutionize patient care and outcomes while empowering orthopedic professionals with cutting-edge solutions.”
Copy to clipboard 
